Search alternatives:
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
m decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 m » 12 mm (Expand Search), 12 mg (Expand Search), 12 _ (Expand Search)
-
461
-
462
(A) Decreased DNA CpG methylation at the CpG island of the gene locus in Th2 cells
Published 2011“…Th2 cells were treated with 5-Aza for 2 d, and mRNA expression was determined by a quantitative RT-PCR system. …”
-
463
-
464
-
465
-
466
-
467
-
468
-
469
-
470
-
471
-
472
-
473
-
474
Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients
Published 2014“…</p><p></p><p></p><p>Conclusions</p><p>This study shows decreased serum anti-inflammatory miR-146a, increased pro-inflammatory IL-8 and increased HGF (a vascular/insular repair factor) as discriminating markers of failure of glucose control occurring on the background of obesity and dyslipidemia.…”
-
475
Fluoxetine decreases the levels of abundant neuropeptides (NPY and CART) in hypothalamic differentiated neuroprogenitor cells.
Published 2014“…<p>Fluoxetine decreases the mRNA levels of neuropeptides that are abundant in differentiated hypothalamic neuroprogenitor cultures NPY (<b>A</b>) and CART (<b>D</b>), but has no effect in the mRNA of AgRP (<b>B</b>) and POMC (<b>C</b>). …”
-
476
-
477
-
478
Anti-TGFβ antibody treatment decreases tumor burden in tumor-bearing mice.
Published 2013“…<p><b>Panel a:</b> Representative H&E sections (5×) of tibia from tumor-bearing mice treated with control antibody (13C4) or anti-TGFβ antibody (1D11). …”
-
479
-
480